Skip to main content
TipRanks
Go Ultimate75% OFF

Novo Nordisk (0TDD) Stock Statistics & Valuation Metrics

11 Followers

Total Valuation

Novo Nordisk has a market cap or net worth of $185.94B. The enterprise value is $181.06B.

Market Cap
$185.94B
Enterprise Value
$181.06B

Share Statistics

Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
3,390,128,000
Owned by Insiders
―
Owned by Institutions
6.22%

Financial Efficiency

Novo Nordisk’s return on equity (ROE) is 0.53 and return on invested capital (ROIC) is 29.53%.

Return on Equity (ROE)
0.53
Return on Assets (ROA)
0.19
Return on Invested Capital (ROIC)
29.53%
Return on Capital Employed (ROCE)
0.39
Revenue Per Employee
4.49M
Profits Per Employee
1.49M
Employee Count
68,794
Asset Turnover
0.57
Inventory Turnover
1.18

Valuation Ratios

The current PE Ratio of Novo Nordisk is 11.18. Novo Nordisk’s PEG ratio is 1.20.

PE Ratio
11.18
PS Ratio
3.77
PB Ratio
5.77
Price to FCF
27.04
Price to Operating Cash Flow
9.79
PEG Ratio
1.20

Income Statement

In the last 12 months, Novo Nordisk had revenue of 309.06B and earned 102.43B in profits. Earnings per share was 23.06.

Revenue
309.06B
Gross Profit
250.28B
Operating Income
127.66B
Pretax Income
130.54B
Net Income
102.43B
EBITDA
156.73B
Earnings Per Share (EPS)
23.06

Cash Flow

In the last 12 months, operating cash flow was 128.15B and capital expenditures -81.82B, giving a free cash flow of 46.32B billion.

Operating Cash Flow
128.15B
Free Cash Flow
46.32B
Free Cash Flow per Share
10.56

Dividends & Yields

Novo Nordisk pays an annual dividend of ―, resulting in a dividend yield of 4.42%

Dividend Per Share
―
Dividend Yield
4.42%
Payout Ratio
N/A
Free Cash Flow Yield
3.70%
Earnings Yield
9.01%

Stock Price Statistics

Beta
0.86
52-Week Price Change
-15.09%
50-Day Moving Average
40.06
200-Day Moving Average
42.59
Relative Strength Index (RSI)
55.73
Average Volume (3m)
113.48K

Important Dates

Novo Nordisk upcoming earnings date is Feb 03, 2027, Before Open (Not Confirmed).

Last Earnings Date
Nov 04, 2026
Next Earnings Date
Feb 03, 2027
Ex-Dividend Date
―

Financial Position

Novo Nordisk as a current ratio of 0.80, with Debt / Equity ratio of 67.49%

Current Ratio
0.80
Quick Ratio
0.57
Debt to Market Cap
0.09
Net Debt to EBITDA
0.67
Interest Coverage Ratio
30.34

Taxes

In the past 12 months, Novo Nordisk has paid 28.11B in taxes.

Income Tax
28.11B
Effective Tax Rate
0.22

Enterprise Valuation

Novo Nordisk EV to EBITDA ratio is 7.65, with an EV/FCF ratio of 28.98.

EV to Sales
4.04
EV to EBITDA
7.65
EV to Free Cash Flow
28.98
EV to Operating Cash Flow
10.50

Balance Sheet

Novo Nordisk has $49.18B in cash and marketable securities with $134.48B in debt, giving a net cash position of -$85.30B billion.

Cash & Marketable Securities
$49.18B
Total Debt
$134.48B
Net Cash
-$85.30B
Net Cash Per Share
-$25.16
Tangible Book Value Per Share
$24.07

Margins

Gross margin is 80.79%, with operating margin of 42.39%, and net profit margin of 33.92%.

Gross Margin
80.79%
Operating Margin
42.39%
Pretax Margin
43.36%
Net Profit Margin
33.92%
EBITDA Margin
52.81%
EBIT Margin
42.69%

Analyst Forecast

The average price target for Novo Nordisk is $43.04, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target
$43.04
Price Target Upside
4.79% Upside
Analyst Consensus
Neutral
Analyst Count
5
Revenue Growth Forecast
11.16%
EPS Growth Forecast
15.62%

Scores

Smart Score
5
AI Score
―